Benign prostatic hyperplasia (BPH) is a common ailment in men demonstrated by about 50% of men by the age of 60 years and about 90% as the age reaches 85 years. Etiopathogenesis is still not fully clear and there is a wide variety of invasive, less invasive and medical treatment modalities. Traditional understanding links BHP with testosterone but in last few years, a theory linking it to varicocele has been propounded which marks a departure from all traditional theories. Besides, two novel and effective treatment modalities have been introduced in the form of Prostatic artery embolization and Urolift. This article reviews these recent advances in BPH under the light of current literature.